Six hospital-based clinical studies were performed, four in Australia and two in other countries. Five of these studies were randomised, double blind, placebo controlled design and the other study was open.  In all six studies patients were aged from 28 days to three(3) years.  The control product was either low potency colostrum or milk.  Combined analysis of these studies demonstrated a statistically significant reduction in the incidence of rotavirus infection in children given Gastrogard-R_® compared with children not given Gastrogard-R_® (p<0.001)

 Revised Nov 2003